The AI in Precision Medicine Market Size was valued at USD 1.80 Billion in 2023 and is expected to reach USD 18.27 Billion by 2032 and grow at a CAGR of 29.37% over the forecast period 2024-2032.
To Get more information on AI in Precision Medicine Market - Request Free Sample Report
The AI in Precision Medicine Market is growing rapidly, driven by advancements in AI, big data analytics, and genomics. AI enhances precision medicine by enabling accurate diagnosis, personalized treatments, and predictive analytics. Key growth drivers include the adoption of AI-powered diagnostics, rising demand for personalized healthcare, and increased investments in AI-driven research. Statistical insights extend to AI adoption rates, drug discovery success rates, patient outcome improvements, and clinical trial efficiencies. Challenges such as data privacy and regulatory compliance also impact growth. With increasing AI patents and government funding, AI’s role in improving healthcare efficiency and patient-centric treatments is expanding.
Key Drivers:
Increasing Adoption of AI-powered diagnostics and Personalized Treatments Drives the AI in Precision Medicine Market Growth
The growing adoption of AI-powered diagnostic tools and personalized treatment approaches is a significant driver of the AI in Precision Medicine Market. AI enhances precision medicine by analyzing vast datasets, identifying patterns, and providing accurate diagnoses faster than traditional methods. Machine learning algorithms assist in predicting disease progression, enabling early intervention and reducing healthcare costs. AI-driven drug discovery is accelerating the development of targeted therapies, improving treatment efficacy. The rising demand for personalized medicine, fueled by advancements in genomics and biomarker identification, further propels market growth.
Additionally, AI integration in medical imaging and predictive analytics is improving patient outcomes. The increasing collaboration between healthcare providers, pharmaceutical companies, and AI technology firms is fostering innovation in precision medicine. Government initiatives supporting AI adoption in healthcare and rising investments in AI-driven research further contribute to market expansion. As AI technologies evolve, their role in enhancing precision medicine and optimizing treatment strategies will continue to grow.
Restrain:
Stringent Data Privacy Regulations and Ethical Concerns Restrain the AI in Precision Medicine Market Growth
Stringent data privacy regulations and ethical concerns pose significant restraints to the growth of the AI in Precision Medicine Market. The integration of AI in healthcare involves handling vast amounts of sensitive patient data, raising concerns about data security, patient confidentiality, and potential misuse. Regulations such as HIPAA, GDPR, and other region-specific data protection laws impose strict compliance requirements on AI-driven precision medicine solutions. Ethical concerns regarding biased AI algorithms, transparency in decision-making, and the risk of AI-driven misdiagnosis also hinder market adoption. Healthcare organizations face challenges in ensuring AI models are fair, unbiased, and comply with ethical guidelines.
Additionally, resistance from healthcare professionals due to concerns about AI replacing human expertise slows down implementation. Addressing data privacy, ethical considerations, and regulatory compliance is crucial for the widespread adoption of AI in precision medicine.
Opportunities:
Advancements in AI-Driven Drug Discovery and Genomics Create Lucrative Opportunities for the AI in Precision Medicine Market
Advancements in AI-driven drug discovery and genomics present significant growth opportunities for AI in the Precision Medicine Market. AI-powered algorithms are transforming drug discovery by accelerating the identification of potential drug candidates, reducing research costs, and enhancing the efficiency of clinical trials. AI models analyze vast genomic datasets, identifying genetic mutations linked to diseases, and enabling the development of targeted therapies. The increasing use of AI in precision oncology, rare disease treatment, and personalized drug development is driving market expansion.
AI-powered predictive analytics also help in selecting optimal treatment plans and improving patient outcomes. Biopharmaceutical companies are investing heavily in AI-driven research to streamline drug development and improve success rates. The rising integration of AI with next-generation sequencing (NGS) technologies further strengthens precision medicine applications. With continuous innovations in AI algorithms and bioinformatics, the potential for developing breakthrough treatments and revolutionizing personalized healthcare is expanding, offering immense market growth prospects.
Challenges:
Integration Challenges and High Implementation Costs Limit the AI in Precision Medicine Market Expansion
The integration of AI in precision medicine faces significant challenges due to high implementation costs and complex infrastructure requirements. Developing and deploying AI-powered healthcare solutions require substantial investments in advanced computing resources, data storage, and AI model training. Many healthcare organizations, particularly in developing regions, struggle with budget constraints and lack the necessary technological infrastructure.
Additionally, integrating AI with existing electronic health record (EHR) systems, medical imaging platforms, and genomic databases presents interoperability challenges. Healthcare providers also require extensive training to effectively use AI-driven tools, adding to implementation barriers. Resistance from traditional healthcare professionals, concerns over AI replacing human expertise, and difficulties in validating AI algorithms further slow adoption. Moreover, the need for continuous updates, regulatory approvals, and maintenance adds to the overall cost. Overcoming these challenges requires strategic investments, cross-industry collaborations, and regulatory support to enhance AI adoption and maximize its benefits in precision medicine.
By Component
The Software segment dominated the AI in Precision Medicine Market in 2023, accounting for 58% of the total revenue, driven by increasing adoption of AI-powered platforms for diagnostics, drug discovery, and patient management. AI-based software solutions enable advanced data analysis, predictive modeling, and real-time clinical decision support, enhancing precision medicine applications. Companies are investing in AI-driven platforms to improve healthcare outcomes and streamline workflows.
For instance, IBM Watson Health continues to expand its AI-driven oncology solutions, helping doctors tailor cancer treatments based on genetic and clinical data. Tempus AI launched new AI-powered software for genomic sequencing and predictive analytics, enhancing personalized treatment plans.
NVIDIA Clara, a healthcare AI platform, is empowering researchers with deep learning models for medical imaging and genomics. Additionally, Microsoft’s Project InnerEye leverages AI for precision radiotherapy, improving accuracy in cancer treatment planning. The rise in AI software adoption is further fueled by cloud-based platforms that integrate electronic health records (EHRs) and real-world patient data, allowing seamless AI deployment across healthcare institutions.
By Technology
The Deep Learning segment dominated the AI in Precision Medicine Market in 2023, accounting for 49% of the total revenue, driven by its superior ability to analyze complex medical data, recognize patterns, and enhance clinical decision-making. Deep learning algorithms power AI-driven diagnostics, drug discovery, and personalized treatment plans by processing vast datasets, including medical imaging, genomic sequences, and patient histories. Leading companies are leveraging deep learning to improve precision medicine applications.
For instance, Google DeepMind’s AlphaFold revolutionized protein structure prediction, accelerating drug discovery and disease modeling. IBM Watson Health has integrated deep learning into oncology solutions, aiding in cancer diagnosis and treatment recommendations. PathAI launched AI-powered deep learning models for pathology image analysis, improving diagnostic accuracy.
Additionally, NVIDIA’s MONAI framework enhances medical imaging AI models, enabling more precise disease detection. Deep learning’s role in genomics is also expanding, with Illumina utilizing AI-powered sequencing tools to identify genetic mutations linked to diseases. The integration of deep learning in precision medicine is improving patient outcomes by enabling real-time, data-driven insights.
By Deployment
The Cloud-Based segment dominated the AI in Precision Medicine Market in 2023, accounting for 69% of the total revenue, driven by the increasing demand for scalable, flexible, and secure AI solutions in healthcare. Cloud-based AI platforms enable seamless integration of vast medical datasets, including electronic health records (EHRs), genomic sequences, and imaging data, facilitating real-time analysis and personalized treatment recommendations. Companies are continuously innovating in this space to enhance AI-driven precision medicine applications.
Additionally, NVIDIA’s Clara Parabricks utilizes cloud-based AI for accelerating genomic sequencing and analysis. Cloud deployment enhances collaboration between research institutions, hospitals, and pharmaceutical companies, allowing AI algorithms to access diverse datasets for improved predictive accuracy. The cost-effectiveness, real-time accessibility, and data security of cloud-based AI solutions are driving their widespread adoption in precision medicine.
By Therapeutic Area
The Oncology segment dominated the AI in Precision Medicine Market in 2023, accounting for 48% of the total revenue, driven by the rising prevalence of cancer and the growing need for AI-powered solutions in early detection, diagnosis, and personalized treatment. AI is revolutionizing oncology by analyzing vast datasets, including medical imaging, genomic profiles, and clinical records, to identify cancer patterns and recommend targeted therapies. Leading companies are leveraging AI to enhance oncology precision medicine. IBM Watson for Oncology uses AI to provide evidence-based treatment recommendations, assisting oncologists in personalized decision-making.
Additionally, Paige AI has introduced deep learning-powered pathology solutions to assist in diagnosing complex cancer cases with higher accuracy. AI-driven advancements in liquid biopsy analysis, predictive analytics for tumor progression, and AI-assisted radiotherapy planning are further optimizing cancer treatment. The increasing adoption of AI in oncology is enhancing survival rates, minimizing treatment side effects, and reducing diagnostic errors. As AI continues to evolve, its role in precision oncology will be crucial in transforming cancer care, improving patient outcomes, and driving further growth in the AI Precision Medicine Market.
By Application
The Drug Discovery & Development segment dominated the AI in Precision Medicine Market in 2023, accounting for 44% of the total revenue, driven by the increasing adoption of AI to accelerate drug identification, optimize clinical trials, and develop personalized therapies. AI-powered platforms are revolutionizing the pharmaceutical industry by analyzing vast biological datasets, predicting drug-target interactions, and reducing the time and cost associated with traditional drug development. Leading companies are integrating AI to enhance precision medicine approaches in drug discovery. BenevolentAI has developed AI-driven drug discovery models that identify novel therapeutic targets for complex diseases.
Additionally, Exscientia has launched AI-designed drug candidates that have entered clinical trials, showcasing AI’s ability to streamline precision drug development. AI is also transforming biomarker discovery, allowing pharmaceutical companies to develop targeted therapies based on genetic profiles. The increasing integration of AI in precision medicine is improving drug repurposing, optimizing treatment efficacy, and minimizing adverse reactions.
By End-User
The Healthcare Providers segment dominated the AI in Precision Medicine Market in 2023, accounting for 38% of the total revenue, driven by the increasing adoption of AI-powered solutions for disease diagnosis, treatment planning, and patient management. Healthcare providers, including hospitals, clinics, and research institutions, are leveraging AI to enhance precision medicine by integrating vast amounts of patient data, genomic insights, and medical imaging for personalized care. AI-driven clinical decision support systems assist physicians in making accurate diagnoses and selecting targeted treatments. Several companies are innovating AI solutions to support healthcare providers in precision medicine.
Additionally, GE Healthcare’s AI-enabled medical imaging technologies are advancing precision diagnostics, reducing diagnostic errors, and improving workflow efficiency. AI-powered predictive analytics is enabling healthcare providers to anticipate disease progression, reducing hospital readmissions and improving patient outcomes. The growing integration of AI with electronic health records (EHRs) and telemedicine platforms further strengthens the role of AI in healthcare. As AI adoption continues to rise, healthcare providers will remain at the forefront of precision medicine, driving improved patient care and fueling market growth.
North America led the AI in Precision Medicine Market in 2023, accounting for the largest market share, estimated to be around 46%. The dominance of this region is driven by advanced healthcare infrastructure, significant investments in AI-driven healthcare technologies, and widespread adoption of precision medicine solutions. The presence of leading AI and healthcare companies, such as IBM Watson Health, NVIDIA, and Tempus AI, has accelerated AI integration in diagnostics, drug discovery, and personalized treatment planning.
Additionally, the high adoption of electronic health records (EHRs), cloud-based AI platforms, and AI-powered genomics research strengthens the region’s leadership in precision medicine. The increasing demand for AI-driven oncology solutions, predictive analytics, and real-time clinical decision support has cemented North America’s position as the market leader.
Europe emerged as the fastest-growing region in the AI in Precision Medicine Market in 2023, with an estimated CAGR of 36.13%. This rapid growth is fueled by increasing government funding, advancements in AI-driven healthcare research, and rising adoption of personalized medicine. The European Union’s Horizon Europe Program is actively supporting AI-driven innovations in healthcare, accelerating precision medicine applications.
Additionally, AI is being increasingly integrated into genomics research, digital pathology, and radiology solutions, enhancing disease detection and treatment planning. Countries like Germany, the UK, and France are at the forefront of AI adoption in healthcare, driven by favorable regulations and increasing collaborations between healthcare providers and AI developers. The rapid digitalization of healthcare infrastructure and rising awareness of AI’s potential in personalized treatments are expected to sustain Europe’s strong growth momentum in the precision medicine market.
Get Customized Report as per Your Business Requirement - Enquiry Now
Some of the major players in the AI in Precision Medicine Market are:
BenevolentAI (Benevolent Platform, Optibrium)
Deep Genomics (AI Workbench, Genetic Medicine Program)
Exscientia (Centaur Chemist, Centaur Biologist, Personalized Drug Discovery Platform)
Foundation Medicine, Inc. (FoundationOne CDx, FoundationOne Liquid CDx)
Grail, Inc. (Galleri, Lunar-2)
Guardant Health, Inc. (Guardant360, Guardant Reveal, GuardantOMNI)
Insilico Medicine (Pharma.AI, PandaOmics, Chemistry42)
PathAI, Inc. (PathExplore, AIM-PD-L1, AIM-HER2)
Tempus AI, Inc. (Tempus Lens, Tempus xT, Tempus One)
Verge Genomics (CONVERGE, AI-Driven Drug Discovery Pipeline)
Zephyr AI (Zephyr Oncology, Zephyr Insights)
Flatiron Health (OncoEMR, Flatiron Assist)
Paige AI, Inc. (Paige Prostate, Paige Breast, Paige Lymph Node)
Proscia Inc. (Concentriq for Research, Concentriq for Clinical Diagnostics)
Predictive Oncology (PeDAL, Helomics D-CHIP)
Nucleai, Inc. (AI-Powered Spatial Biology Platform, Precision Oncology Biomarker Discovery)
Densitas Inc. (intelliMammo, Densitas Risk, Densitas Density AI)
Valar Labs (Valar Pathology AI, AI-Driven Oncology Biomarker Platform)
Berg LLC (Interrogative Biology Platform, BPM 31510)
Owkin (Owkin Platform, Owkin Loop, Owkin Substra)
In February 2025, Tempus AI reported a fourth-quarter loss of $0.18 per share on revenues of $200.7 million, leading to a 17% drop in stock value. The company attributed increased operating expenses to an expanded sales force and growth in testing volume.
In November 2023, Exscientia entered into a multi-year strategic collaboration with Tempus to advance biomarker-driven therapeutic development using a data-first approach. This partnership allows Exscientia access to Tempus' extensive library of de-identified, multimodal data to further its therapeutic development efforts.
In January 2025, BenevolentAI announced plans to delist from Euronext Amsterdam and is considering relisting in London from 2026. This decision follows significant job cuts and cost reductions after founder Ken Mulvany regained control of the board, aiming to refocus on developing AI technology for drug discovery.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | USD 1.80 Billion |
| Market Size by 2032 | USD 18.27 Billion |
| CAGR | CAGR of 29.37% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | •By Component (Software, Hardware, Services) •By Technology (Deep Learning, Querying Method, Natural language processing, Context aware processing, Others) •By Deployment (Cloud Based, On-Premise, Hybrid) •By Therapeutic Area (Oncology, Rare Diseases, Infectious Diseases, Neurology, Cardiology, Hematology, Others) •By Application (Drug Discovery & Development [Drug Discovery, Drug Repurposing, De Novo Drug Design, Drug Optimization, Safety & Toxicity, Clinical Development], Diagnostics & Screening [Risk Assessment & Patient Stratification, Disease Screening, Disease Diagnosis, Disease Progression, Staging, And Prognosis], Therapeutics [Therapy Selection & Planning, Therapy Monitoring, Post-Treatment Surveillance & Follow-Up]) •By End-User (Healthcare Providers, Pharmaceutical & Biotechnology Companies, Medical Device & Equipment Companies, Research Centers, Academic Institutes, And Government Organizations, Others) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | Tempus AI, Inc., Exscientia, BenevolentAI, Deep Genomics, Insilico Medicine, PathAI, Inc., Verge Genomics, Guardant Health, Inc., Grail, Inc., Foundation Medicine, Inc. and other key players |
Ans: The AI in Precision Medicine Market is expected to grow at a CAGR of 29.37% during 2024-2032.
Ans: The AI in Precision Medicine Market size was USD 1.80 billion in 2023 and is expected to Reach USD 18.27 billion by 2032.
Ans: The major growth factor of the AI in Precision Medicine Market is the increasing adoption of AI-driven diagnostics, personalized treatment planning, and drug discovery to enhance healthcare outcomes.
Ans: The Oncology segment dominated the AI in Precision Medicine Market.
Ans: North America dominated the AI in Precision Medicine Market in 2023.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Funding & Investment Trends
5.2 Emission Standards Compliance
5.3 Regulatory Approvals & Compliance Trends
5.4 Patient Outcomes & Treatment Success Rates
5.4 Cost Reduction & Efficiency Gains
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and supply chain strategies
6.4.3 Expansion plans and new product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. AI in Precision Medicine Market Segmentation, By Component
7.1 Chapter Overview
7.2 Software
7.2.1 Software Market Trends Analysis (2020-2032)
7.2.2 Software Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Hardware
7.3.1 Hardware Market Trends Analysis (2020-2032)
7.3.2 Hardware Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4 Services
7.4.1 Services Market Trends Analysis (2020-2032)
7.4.2 Services Market Size Estimates and Forecasts to 2032 (USD Billion)
8. AI in Precision Medicine Market Segmentation, By Technology
8.1 Chapter Overview
8.2 Deep Learning
8.2.1 Deep Learning Market Trends Analysis (2020-2032)
8.2.2 Deep Learning Market Size Estimates And Forecasts To 2032 (USD Billion)
8.3 Querying Method
8.3.1 Querying Method Motor Market Trends Analysis (2020-2032)
8.3.2 Querying Method Motor Market Size Estimates And Forecasts To 2032 (USD Billion)
8.4 Natural Language Processing
8.4.1 Natural Language Processing Market Trends Analysis (2020-2032)
8.4.2 Natural Language Processing Market Size Estimates And Forecasts To 2032 (USD Billion)
8.5 Context Aware Processing
8.5.1 Context Aware Processing Market Trends Analysis (2020-2032)
8.5.2 Context Aware Processing Market Size Estimates And Forecasts To 2032 (USD Billion)
8.6 Others
8.6.1 Others Market Trends Analysis (2020-2032)
8.6.2 Others Market Size Estimates And Forecasts To 2032 (USD Billion)
9. AI in Precision Medicine Market Segmentation, By Deployment
9.1 Chapter Overview
9.2 Cloud Based
9.2.1 Cloud Based Market Trends Analysis (2020-2032)
9.2.2 Cloud Based Market Size Estimates And Forecasts To 2032 (USD Billion)
9.3 On-Premise
9.3.1 On-Premise Market Trends Analysis (2020-2032)
9.3.2 On-Premise Market Size Estimates And Forecasts To 2032 (USD Billion)
9.4 Hybrid
9.4.1 Hybrid Market Trends Analysis (2020-2032)
9.4.2 Hybrid Market Size Estimates And Forecasts To 2032 (USD Billion)
10. AI in Precision Medicine Market Segmentation, By Therapeutic Area
10.1 Chapter Overview
10.2 Oncology
10.2.1 Oncology Market Trends Analysis (2020-2032)
10.2.2 Oncology Market Size Estimates And Forecasts To 2032 (USD Billion)
10.3 Rare Diseases
10.3.1 Rare Diseases Market Trends Analysis (2020-2032)
10.3.2 Rare Diseases Market Size Estimates And Forecasts To 2032 (USD Billion)
10.4 Infectious Diseases
10.4.1 Infectious Diseases Market Trends Analysis (2020-2032)
10.4.2 Infectious Diseases Market Size Estimates And Forecasts To 2032 (USD Billion)
10.5 Neurology
10.5.1 Neurology Market Trends Analysis (2020-2032)
10.5.2 Neurology Market Size Estimates And Forecasts To 2032 (USD Billion)
10.6 Cardiology
10.6.1 Cardiology Market Trends Analysis (2020-2032)
10.6.2 Cardiology Market Size Estimates And Forecasts To 2032 (USD Billion)
10.7 Hematology
10.7.1 Hematology Market Trends Analysis (2020-2032)
10.7.2 Hematology Market Size Estimates And Forecasts To 2032 (USD Billion)
10.8 Others
10.8.1 Others Market Trends Analysis (2020-2032)
10.8.2 Others Market Size Estimates And Forecasts To 2032 (USD Billion)
11. AI in Precision Medicine Market Segmentation, By Application
11.1 Chapter Overview
11.2 Drug Discovery & Development
11.2.1 Drug Discovery & Development Market Trends Analysis (2020-2032)
11.2.2 Drug Discovery & Development Market Size Estimates And Forecasts To 2032 (USD Billion)
11.2.3 Drug Discovery
11.2.3.1 Drug Discovery Market Trends Analysis (2020-2032)
11.2.3.2 Drug Discovery Market Size Estimates And Forecasts To 2032 (USD Billion)
11.2.4 Drug Repurposing
11.2.4.1 Drug Repurposing Market Trends Analysis (2020-2032)
11.2.4.2 Drug Repurposing Market Size Estimates And Forecasts To 2032 (USD Billion)
11.2.5 De Novo Drug Design
11.2.5.1 De Novo Drug Design Market Trends Analysis (2020-2032)
11.2.5.2 De Novo Drug Design Market Size Estimates And Forecasts To 2032 (USD Billion)
11.2.6 Drug Optimization
11.2.6.1 Drug Optimization Market Trends Analysis (2020-2032)
11.2.6.2 Drug Optimization Market Size Estimates And Forecasts To 2032 (USD Billion)
11.2.7 Safety & Toxicity
11.2.7.1 Safety & Toxicity Market Trends Analysis (2020-2032)
11.2.7.2 Safety & Toxicity Market Size Estimates And Forecasts To 2032 (USD Billion)
11.2.8 Clinical Development
11.2.8.1 Clinical Development Market Trends Analysis (2020-2032)
11.2.8.2 Clinical Development Market Size Estimates And Forecasts To 2032 (USD Billion)
11.3 Diagnostics & Screening
11.3.1 Diagnostics & Screening Vehicles Market Trends Analysis (2020-2032)
11.3.2 Diagnostics & Screening Market Size Estimates And Forecasts To 2032 (USD Billion)
11.3.3 Risk Assessment & Patient Stratification
11.3.3.1 Risk Assessment & Patient Stratification Market Trends Analysis (2020-2032)
11.3.3.2 Risk Assessment & Patient Stratification Market Size Estimates And Forecasts To 2032 (USD Billion)
11.3.4 Disease Screening
11.3.4.1 Disease Screening Market Trends Analysis (2020-2032)
11.3.4.2 Disease Screening Market Size Estimates And Forecasts To 2032 (USD Billion)
11.3.5 Disease Diagnosis
11.3.5.1 Disease Diagnosis Market Trends Analysis (2020-2032)
11.3.5.2 Disease Diagnosis Market Size Estimates And Forecasts To 2032 (USD Billion)
11.3.6 Disease Progression, Staging, And Prognosis
11.3.6.1 Disease Progression, Staging, And Prognosis Market Trends Analysis (2020-2032)
11.3.6.2 Disease Progression, Staging, And Prognosis Market Size Estimates And Forecasts To 2032 (USD Billion)
11.4 Therapeutics
11.4.1 Therapeutics Market Trends Analysis (2020-2032)
11.4.2 Therapeutics Market Size Estimates And Forecasts To 2032 (USD Billion)
11.4.3 Therapy Selection & Planning
11.4.3.1 Therapy Selection & Planning Market Trends Analysis (2020-2032)
11.4.3.2 Therapy Selection & Planning Market Size Estimates And Forecasts To 2032 (USD Billion)
11.4.4 Therapy Monitoring
11.4.4.1 Therapy Monitoring Market Trends Analysis (2020-2032)
11.4.4.2 Therapy Monitoring Market Size Estimates And Forecasts To 2032 (USD Billion)
11.4.5 Post-Treatment Surveillance & Follow-Up
11.4.5.1 Post-Treatment Surveillance & Follow-Up Market Trends Analysis (2020-2032)
11.4.5.2 Post-Treatment Surveillance & Follow-Up Market Size Estimates And Forecasts To 2032 (USD Billion)
12. AI in Precision Medicine Market Segmentation, By End-User
12.1 Chapter Overview
12.2 Healthcare Providers
12.2.1 Healthcare Providers Market Trends Analysis (2020-2032)
12.2.2 Healthcare Providers Market Size Estimates And Forecasts To 2032 (USD Billion)
12.3 Pharmaceutical & Biotechnology Companies
12.3.1 Pharmaceutical & Biotechnology Companies Market Trends Analysis (2020-2032)
12.3.2 Pharmaceutical & Biotechnology Companies Market Size Estimates And Forecasts To 2032 (USD Billion)
12.4 Medical Device & Equipment Companies
12.4.1 Medical Device & Equipment Companies Market Trends Analysis (2020-2032)
12.4.2 Medical Device & Equipment Companies Market Size Estimates And Forecasts To 2032 (USD Billion)
12.5 Research Centers, Academic Institutes, And Government Organizations
12.5.1 Research Centers, Academic Institutes, And Government Organizations Market Trends Analysis (2020-2032)
12.5.2 Research Centers, Academic Institutes, And Government Organizations Market Size Estimates And Forecasts To 2032 (USD Billion)
12.6 Others
12.6.1 Others Market Trends Analysis (2020-2032)
12.6.2 Others Market Size Estimates And Forecasts To 2032 (USD Billion)
13. Regional Analysis
13.1 Chapter Overview
13.2 North America
13.2.1 Trends Analysis
13.2.2 North America AI in Precision Medicine Market Estimates And Forecasts, By Country (2020-2032) (USD Billion)
13.2.3 North America AI in Precision Medicine Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
13.2.4 North America AI in Precision Medicine Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
13.2.5 North America AI in Precision Medicine Market Estimates And Forecasts, By Deployment (2020-2032) (USD Billion)
13.2.6 North America AI in Precision Medicine Market Estimates And Forecasts, By Therapeutic Area (2020-2032) (USD Billion)
13.2.7 North America AI in Precision Medicine Market Estimates And Forecasts, By Application (2020-2032) (USD Billion)
13.2.8 North America AI in Precision Medicine Market Segmentation, By End-User (2020-2032) (USD Billion)
13.2.9 USA
13.2.9.1 USA AI in Precision Medicine Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
13.2.9.2 USA AI in Precision Medicine Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
13.2.9.3 USA AI in Precision Medicine Market Estimates And Forecasts, By Deployment (2020-2032) (USD Billion)
13.2.9.4 USA AI in Precision Medicine Market Estimates And Forecasts, By Therapeutic Area (2020-2032) (USD Billion)
13.2.9.5 USA AI in Precision Medicine Market Estimates And Forecasts, By Application (2020-2032) (USD Billion)
13.2.9.6 USA AI in Precision Medicine Market Segmentation, By End-User (2020-2032) (USD Billion)
13.2.10 Canada
13.2.10.1 Canada AI in Precision Medicine Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
13.2.10.2 Canada AI in Precision Medicine Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
13.2.10.3 Canada AI in Precision Medicine Market Estimates And Forecasts, By Deployment (2020-2032) (USD Billion)
13.2.10.4 Canada AI in Precision Medicine Market Estimates And Forecasts, By Therapeutic Area (2020-2032) (USD Billion)
13.2.10.5 Canada AI in Precision Medicine Market Estimates And Forecasts, By Application (2020-2032) (USD Billion)
13.2.10.6 Canada AI in Precision Medicine Market Segmentation, By End-User (2020-2032) (USD Billion)
13.2.11 Mexico
13.2.11.1 Mexico AI in Precision Medicine Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
13.2.11.2 Mexico AI in Precision Medicine Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
13.2.11.3 Mexico AI in Precision Medicine Market Estimates And Forecasts, By Deployment (2020-2032) (USD Billion)
13.2.11.4 Mexico AI in Precision Medicine Market Estimates And Forecasts, By Therapeutic Area (2020-2032) (USD Billion)
13.2.11.5 Mexico AI in Precision Medicine Market Estimates And Forecasts, By Application (2020-2032) (USD Billion)
13.2.11.6 Mexico AI in Precision Medicine Market Segmentation, By End-User (2020-2032) (USD Billion)
13.3 Europe
13.3.1 Eastern Europe
13.3.1.1 Trends Analysis
13.3.1.2 Eastern Europe AI in Precision Medicine Market Estimates And Forecasts, By Country (2020-2032) (USD Billion)
13.3.1.3 Eastern Europe AI in Precision Medicine Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
13.3.1.4 Eastern Europe AI in Precision Medicine Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
13.3.1.5 Eastern Europe AI in Precision Medicine Market Estimates And Forecasts, By Deployment (2020-2032) (USD Billion)
13.3.1.6 Eastern Europe AI in Precision Medicine Market Estimates And Forecasts, By Therapeutic Area (2020-2032) (USD Billion)
13.3.1.7 Eastern Europe AI in Precision Medicine Market Estimates And Forecasts, By Application (2020-2032) (USD Billion)
13.3.1.8 Eastern Europe AI in Precision Medicine Market Segmentation, By End-User (2020-2032) (USD Billion)
13.3.1.9 Poland
13.3.1.9.1 Poland AI in Precision Medicine Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
13.3.1.9.2 Poland AI in Precision Medicine Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
13.3.1.9.3 Poland AI in Precision Medicine Market Estimates And Forecasts, By Deployment (2020-2032) (USD Billion)
13.3.1.9.4 Poland AI in Precision Medicine Market Estimates And Forecasts, By Therapeutic Area (2020-2032) (USD Billion)
13.3.1.9.5 Poland AI in Precision Medicine Market Estimates And Forecasts, By Application (2020-2032) (USD Billion)
13.3.1.9.6 Poland AI in Precision Medicine Market Segmentation, By End-User (2020-2032) (USD Billion)
13.3.1.10 Romania
13.3.1.10.1 Romania AI in Precision Medicine Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
13.3.1.10.2 Romania AI in Precision Medicine Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
13.3.1.10.3 Romania AI in Precision Medicine Market Estimates And Forecasts, By Deployment (2020-2032) (USD Billion)
13.3.1.10.4 Romania AI in Precision Medicine Market Estimates And Forecasts, By Therapeutic Area (2020-2032) (USD Billion)
13.3.1.10.5 Romania AI in Precision Medicine Market Estimates And Forecasts, By Application (2020-2032) (USD Billion)
13.3.1.10.6 Romania AI in Precision Medicine Market Segmentation, By End-User (2020-2032) (USD Billion)
13.3.1.11 Hungary
13.3.1.11.1 Hungary AI in Precision Medicine Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
13.3.1.11.2 Hungary AI in Precision Medicine Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
13.3.1.11.3 Hungary AI in Precision Medicine Market Estimates And Forecasts, By Deployment (2020-2032) (USD Billion)
13.3.1.11.4 Hungary AI in Precision Medicine Market Estimates And Forecasts, By Therapeutic Area (2020-2032) (USD Billion)
13.3.1.11.5 Hungary AI in Precision Medicine Market Estimates And Forecasts, By Application (2020-2032) (USD Billion)
13.3.1.11.6 Hungary AI in Precision Medicine Market Segmentation, By End-User (2020-2032) (USD Billion)
13.3.1.12 Turkey
13.3.1.12.1 Turkey AI in Precision Medicine Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
13.3.1.12.2 Turkey AI in Precision Medicine Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
13.3.1.12.3 Turkey AI in Precision Medicine Market Estimates And Forecasts, By Deployment (2020-2032) (USD Billion)
13.3.1.12.4 Turkey AI in Precision Medicine Market Estimates And Forecasts, By Therapeutic Area (2020-2032) (USD Billion)
13.3.1.12.5 Turkey AI in Precision Medicine Market Estimates And Forecasts, By Application (2020-2032) (USD Billion)
13.3.1.12.6 Turkey AI in Precision Medicine Market Segmentation, By End-User (2020-2032) (USD Billion)
13.3.1.13 Rest Of Eastern Europe
13.3.1.13.1 Rest Of Eastern Europe AI in Precision Medicine Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
13.3.1.13.2 Rest Of Eastern Europe AI in Precision Medicine Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
13.3.1.13.3 Rest Of Eastern Europe AI in Precision Medicine Market Estimates And Forecasts, By Deployment (2020-2032) (USD Billion)
13.3.1.13.4 Rest Of Eastern Europe AI in Precision Medicine Market Estimates And Forecasts, By Therapeutic Area (2020-2032) (USD Billion)
13.3.1.13.5 Rest Of Eastern Europe AI in Precision Medicine Market Estimates And Forecasts, By Application (2020-2032) (USD Billion)
13.3.1.13.6 Rest Of Eastern Europe AI in Precision Medicine Market Segmentation, By End-User (2020-2032) (USD Billion)
13.3.2 Western Europe
13.3.2.1 Trends Analysis
13.3.2.2 Western Europe AI in Precision Medicine Market Estimates And Forecasts, By Country (2020-2032) (USD Billion)
13.3.2.3 Western Europe AI in Precision Medicine Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
13.3.2.4 Western Europe AI in Precision Medicine Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
13.3.2.5 Western Europe AI in Precision Medicine Market Estimates And Forecasts, By Deployment (2020-2032) (USD Billion)
13.3.2.6 Western Europe AI in Precision Medicine Market Estimates And Forecasts, By Therapeutic Area (2020-2032) (USD Billion)
13.3.2.7 Western Europe AI in Precision Medicine Market Estimates And Forecasts, By Application (2020-2032) (USD Billion)
13.3.2.8 Western Europe AI in Precision Medicine Market Segmentation, By End-User (2020-2032) (USD Billion)
13.3.2.9 Germany
13.3.2.9.1 Germany AI in Precision Medicine Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
13.3.2.9.2 Germany AI in Precision Medicine Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
13.3.2.9.3 Germany AI in Precision Medicine Market Estimates And Forecasts, By Deployment (2020-2032) (USD Billion)
13.3.2.9.4 Germany AI in Precision Medicine Market Estimates And Forecasts, By Therapeutic Area (2020-2032) (USD Billion)
13.3.2.9.5 Germany AI in Precision Medicine Market Estimates And Forecasts, By Application (2020-2032) (USD Billion)
13.3.2.9.6 Germany AI in Precision Medicine Market Segmentation, By End-User (2020-2032) (USD Billion)
13.3.2.10 France
13.3.2.10.1 France AI in Precision Medicine Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
13.3.2.10.2 France AI in Precision Medicine Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
13.3.2.10.3 France AI in Precision Medicine Market Estimates And Forecasts, By Deployment (2020-2032) (USD Billion)
13.3.2.10.4 France AI in Precision Medicine Market Estimates And Forecasts, By Therapeutic Area (2020-2032) (USD Billion)
13.3.2.10.5 France AI in Precision Medicine Market Estimates And Forecasts, By Application (2020-2032) (USD Billion)
13.3.2.10.6 France AI in Precision Medicine Market Segmentation, By End-User (2020-2032) (USD Billion)
13.3.2.11 UK
13.3.2.11.1 UK AI in Precision Medicine Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
13.3.2.11.2 UK AI in Precision Medicine Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
13.3.2.11.3 UK AI in Precision Medicine Market Estimates And Forecasts, By Deployment (2020-2032) (USD Billion)
13.3.2.11.4 UK AI in Precision Medicine Market Estimates And Forecasts, By Therapeutic Area (2020-2032) (USD Billion)
13.3.2.11.5 UK AI in Precision Medicine Market Estimates And Forecasts, By Application (2020-2032) (USD Billion)
13.3.2.11.6 UK AI in Precision Medicine Market Segmentation, By End-User (2020-2032) (USD Billion)
13.3.2.12 Italy
13.3.2.12.1 Italy AI in Precision Medicine Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
13.3.2.12.2 Italy AI in Precision Medicine Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
13.3.2.12.3 Italy AI in Precision Medicine Market Estimates And Forecasts, By Deployment (2020-2032) (USD Billion)
13.3.2.12.4 Italy AI in Precision Medicine Market Estimates And Forecasts, By Therapeutic Area (2020-2032) (USD Billion)
13.3.2.12.5 Italy AI in Precision Medicine Market Estimates And Forecasts, By Application (2020-2032) (USD Billion)
13.3.2.12.6 Italy AI in Precision Medicine Market Segmentation, By End-User (2020-2032) (USD Billion)
13.3.2.13 Spain
13.3.2.13.1 Spain AI in Precision Medicine Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
13.3.2.13.2 Spain AI in Precision Medicine Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
13.3.2.13.3 Spain AI in Precision Medicine Market Estimates And Forecasts, By Deployment (2020-2032) (USD Billion)
13.3.2.13.4 Spain AI in Precision Medicine Market Estimates And Forecasts, By Therapeutic Area (2020-2032) (USD Billion)
13.3.2.13.5 Spain AI in Precision Medicine Market Estimates and Forecasts, By Application (2020-2032) (USD -13824)
13.3.2.13.6 Spain AI in Precision Medicine Market Segmentation, By End-User (2020-2032) (USD Billion)
13.3.2.14 Netherlands
13.3.2.14.1 Netherlands AI in Precision Medicine Market Estimates and Forecasts, By Component (2020-2032) (USD Billion)
13.3.2.14.2 Netherlands AI in Precision Medicine Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
13.3.2.14.3 Netherlands AI in Precision Medicine Market Estimates And Forecasts, By Deployment (2020-2032) (USD Billion)
13.3.2.14.4 Netherlands AI in Precision Medicine Market Estimates And Forecasts, By Therapeutic Area (2020-2032) (USD Billion)
13.3.2.14.5 Netherlands AI in Precision Medicine Market Estimates And Forecasts, By Application (2020-2032) (USD Billion)
13.3.2.14.6 Netherlands AI in Precision Medicine Market Segmentation, By End-User (2020-2032) (USD Billion)
13.3.2.15 Switzerland
13.3.2.15.1 Switzerland AI in Precision Medicine Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
13.3.2.15.2 Switzerland AI in Precision Medicine Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
13.3.2.15.3 Switzerland AI in Precision Medicine Market Estimates And Forecasts, By Deployment (2020-2032) (USD Billion)
13.3.2.15.4 Switzerland AI in Precision Medicine Market Estimates And Forecasts, By Therapeutic Area (2020-2032) (USD Billion)
13.3.2.15.5 Switzerland AI in Precision Medicine Market Estimates And Forecasts, By Application (2020-2032) (USD Billion)
13.3.2.15.6 Switzerland AI in Precision Medicine Market Segmentation, By End-User (2020-2032) (USD Billion)
13.3.2.16 Austria
13.3.2.16.1 Austria AI in Precision Medicine Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
13.3.2.16.2 Austria AI in Precision Medicine Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
13.3.2.16.3 Austria AI in Precision Medicine Market Estimates And Forecasts, By Deployment (2020-2032) (USD Billion)
13.3.2.16.4 Austria AI in Precision Medicine Market Estimates And Forecasts, By Therapeutic Area (2020-2032) (USD Billion)
13.3.2.16.5 Austria AI in Precision Medicine Market Estimates And Forecasts, By Application (2020-2032) (USD Billion)
13.3.2.16.6 Austria AI in Precision Medicine Market Segmentation, By End-User (2020-2032) (USD Billion)
13.3.2.17 Rest Of Western Europe
13.3.2.17.1 Rest Of Western Europe AI in Precision Medicine Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
13.3.2.17.2 Rest Of Western Europe AI in Precision Medicine Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
13.3.2.17.3 Rest Of Western Europe AI in Precision Medicine Market Estimates And Forecasts, By Deployment (2020-2032) (USD Billion)
13.3.2.17.4 Rest Of Western Europe AI in Precision Medicine Market Estimates And Forecasts, By Therapeutic Area (2020-2032) (USD Billion)
13.3.2.17.5 Rest Of Western Europe AI in Precision Medicine Market Estimates And Forecasts, By Application (2020-2032) (USD Billion)
13.3.2.17.6 Rest Of Western Europe AI in Precision Medicine Market Segmentation, By End-User (2020-2032) (USD Billion)
13.4 Asia Pacific
13.4.1 Trends Analysis
13.4.2 Asia Pacific AI in Precision Medicine Market Estimates And Forecasts, By Country (2020-2032) (USD Billion)
13.4.3 Asia Pacific AI in Precision Medicine Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
13.4.4 Asia Pacific AI in Precision Medicine Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
13.4.5 Asia Pacific AI in Precision Medicine Market Estimates And Forecasts, By Deployment (2020-2032) (USD Billion)
13.4.6 Asia Pacific AI in Precision Medicine Market Estimates And Forecasts, By Therapeutic Area (2020-2032) (USD Billion)
13.4.7 Asia Pacific AI in Precision Medicine Market Estimates And Forecasts, By Application (2020-2032) (USD Billion)
13.4.8 Asia Pacific AI in Precision Medicine Market Segmentation, By End-User (2020-2032) (USD Billion)
13.4.9 China
13.4.9.1 China AI in Precision Medicine Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
13.4.9.2 China AI in Precision Medicine Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
13.4.9.3 China AI in Precision Medicine Market Estimates And Forecasts, By Deployment (2020-2032) (USD Billion)
13.4.9.4 China AI in Precision Medicine Market Estimates And Forecasts, By Therapeutic Area (2020-2032) (USD Billion)
13.4.9.5 China AI in Precision Medicine Market Estimates And Forecasts, By Application (2020-2032) (USD Billion)
13.4.9.6 China AI in Precision Medicine Market Segmentation, By End-User (2020-2032) (USD Billion)
13.4.10 India
13.4.10.1 India AI in Precision Medicine Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
13.4.10.2 India AI in Precision Medicine Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
13.4.10.3 India AI in Precision Medicine Market Estimates And Forecasts, By Deployment (2020-2032) (USD Billion)
13.4.10.4 India AI in Precision Medicine Market Estimates And Forecasts, By Therapeutic Area (2020-2032) (USD Billion)
13.4.10.5 India AI in Precision Medicine Market Estimates And Forecasts, By Application (2020-2032) (USD Billion)
13.4.10.6 India AI in Precision Medicine Market Segmentation, By End-User (2020-2032) (USD Billion)
13.4.11 Japan
13.4.11.1 Japan AI in Precision Medicine Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
13.4.11.2 Japan AI in Precision Medicine Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
13.4.11.3 Japan AI in Precision Medicine Market Estimates And Forecasts, By Deployment (2020-2032) (USD Billion)
13.4.11.4 Japan AI in Precision Medicine Market Estimates And Forecasts, By Therapeutic Area (2020-2032) (USD Billion)
13.4.11.5 Japan AI in Precision Medicine Market Estimates And Forecasts, By Application (2020-2032) (USD Billion)
13.4.11.6 Japan AI in Precision Medicine Market Segmentation, By End-User (2020-2032) (USD Billion)
13.4.12 South Korea
13.4.12.1 South Korea AI in Precision Medicine Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
13.4.12.2 South Korea AI in Precision Medicine Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
13.4.12.3 South Korea AI in Precision Medicine Market Estimates And Forecasts, By Deployment (2020-2032) (USD Billion)
13.4.12.4 South Korea AI in Precision Medicine Market Estimates And Forecasts, By Therapeutic Area (2020-2032) (USD Billion)
13.4.12.5 South Korea AI in Precision Medicine Market Estimates And Forecasts, By Application (2020-2032) (USD Billion)
13.4.12.6 South Korea AI in Precision Medicine Market Segmentation, By End-User (2020-2032) (USD Billion)
13.4.13 Vietnam
13.4.13.1 Vietnam AI in Precision Medicine Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
13.4.13.2 Vietnam AI in Precision Medicine Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
13.4.13.3 Vietnam AI in Precision Medicine Market Estimates And Forecasts, By Deployment (2020-2032) (USD Billion)
13.4.13.4 Vietnam AI in Precision Medicine Market Estimates And Forecasts, By Therapeutic Area (2020-2032) (USD Billion)
13.4.13.5 Vietnam AI in Precision Medicine Market Estimates And Forecasts, By Application (2020-2032) (USD Billion)
13.4.13.6 Vietnam AI in Precision Medicine Market Segmentation, By End-User (2020-2032) (USD Billion)
13.4.14 Singapore
13.4.14.1 Singapore AI in Precision Medicine Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
13.4.14.2 Singapore AI in Precision Medicine Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
13.4.14.3 Singapore AI in Precision Medicine Market Estimates And Forecasts, By Deployment (2020-2032) (USD Billion)
13.4.14.4 Singapore AI in Precision Medicine Market Estimates And Forecasts, By Therapeutic Area (2020-2032) (USD Billion)
13.4.14.5 Singapore AI in Precision Medicine Market Estimates And Forecasts, By Application (2020-2032) (USD Billion)
13.4.14.6 Singapore AI in Precision Medicine Market Segmentation, By End-User (2020-2032) (USD Billion)
13.4.15 Australia
13.4.15.1 Australia AI in Precision Medicine Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
13.4.15.2 Australia AI in Precision Medicine Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
13.4.15.3 Australia AI in Precision Medicine Market Estimates And Forecasts, By Deployment (2020-2032) (USD Billion)
13.4.15.4 Australia AI in Precision Medicine Market Estimates And Forecasts, By Therapeutic Area (2020-2032) (USD Billion)
13.4.15.5 Australia AI in Precision Medicine Market Estimates And Forecasts, By Application (2020-2032) (USD Billion)
13.4.15.6 Australia AI in Precision Medicine Market Segmentation, By End-User (2020-2032) (USD Billion)
13.4.16 Rest Of Asia Pacific
13.4.16.1 Rest Of Asia Pacific AI in Precision Medicine Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
13.4.16.2 Rest Of Asia Pacific AI in Precision Medicine Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
13.4.16.3 Rest Of Asia Pacific AI in Precision Medicine Market Estimates And Forecasts, By Deployment (2020-2032) (USD Billion)
13.4.16.4 Rest Of Asia Pacific AI in Precision Medicine Market Estimates And Forecasts, By Therapeutic Area (2020-2032) (USD Billion)
13.4.16.5 Rest Of Asia Pacific AI in Precision Medicine Market Estimates And Forecasts, By Application (2020-2032) (USD Billion)
13.4.16.6 Rest Of Asia Pacific AI in Precision Medicine Market Segmentation, By End-User (2020-2032) (USD Billion)
13.5 Middle East And Africa
13.5.1 Middle East
13.5.1.1 Trends Analysis
13.5.1.2 Middle East AI in Precision Medicine Market Estimates And Forecasts, By Country (2020-2032) (USD Billion)
13.5.1.3 Middle East AI in Precision Medicine Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
13.5.1.4 Middle East AI in Precision Medicine Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
13.5.1.5 Middle East AI in Precision Medicine Market Estimates And Forecasts, By Deployment (2020-2032) (USD Billion)
13.5.1.6 Middle East AI in Precision Medicine Market Estimates And Forecasts, By Therapeutic Area (2020-2032) (USD Billion)
13.5.1.7 Middle East AI in Precision Medicine Market Estimates And Forecasts, By Application (2020-2032) (USD Billion)
13.5.1.8 Middle East AI in Precision Medicine Market Segmentation, By End-User (2020-2032) (USD Billion)
13.5.1.9 UAE
13.5.1.9.1 UAE AI in Precision Medicine Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
13.5.1.9.2 UAE AI in Precision Medicine Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
13.5.1.9.3 UAE AI in Precision Medicine Market Estimates And Forecasts, By Deployment (2020-2032) (USD Billion)
13.5.1.9.4 UAE AI in Precision Medicine Market Estimates And Forecasts, By Therapeutic Area (2020-2032) (USD Billion)
13.5.1.9.5 UAE AI in Precision Medicine Market Estimates And Forecasts, By Application (2020-2032) (USD Billion)
13.5.1.9.6 UAE AI in Precision Medicine Market Segmentation, By End-User (2020-2032) (USD Billion)
13.5.1.10 Egypt
13.5.1.10.1 Egypt AI in Precision Medicine Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
13.5.1.10.2 Egypt AI in Precision Medicine Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
13.5.1.10.3 Egypt AI in Precision Medicine Market Estimates And Forecasts, By Deployment (2020-2032) (USD Billion)
13.5.1.10.4 Egypt AI in Precision Medicine Market Estimates And Forecasts, By Therapeutic Area (2020-2032) (USD Billion)
13.5.1.10.5 Egypt AI in Precision Medicine Market Estimates And Forecasts, By Application (2020-2032) (USD Billion)
13.5.1.10.6 Egypt AI in Precision Medicine Market Segmentation, By End-User (2020-2032) (USD Billion)
13.5.1.11 Saudi Arabia
13.5.1.10.1 Saudi Arabia AI in Precision Medicine Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
13.5.1.11.2 Saudi Arabia AI in Precision Medicine Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
13.5.1.11.3 Saudi Arabia AI in Precision Medicine Market Estimates And Forecasts, By Deployment (2020-2032) (USD Billion)
13.5.1.11.4 Saudi Arabia AI in Precision Medicine Market Estimates And Forecasts, By Therapeutic Area (2020-2032) (USD Billion)
13.5.1.11.5 Saudi Arabia AI in Precision Medicine Market Estimates And Forecasts, By Application (2020-2032) (USD Billion)
13.5.1.11.6 Saudi Arabia AI in Precision Medicine Market Segmentation, By End-User (2020-2032) (USD Billion)
13.5.1.12 Qatar
13.5.1.12.1 Qatar AI in Precision Medicine Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
13.5.1.12.2 Qatar AI in Precision Medicine Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
13.5.1.12.3 Qatar AI in Precision Medicine Market Estimates And Forecasts, By Deployment (2020-2032) (USD Billion)
13.5.1.12.4 Qatar AI in Precision Medicine Market Estimates And Forecasts, By Therapeutic Area (2020-2032) (USD Billion)
13.5.1.12.5 Qatar AI in Precision Medicine Market Estimates And Forecasts, By Application (2020-2032) (USD Billion)
13.5.1.12.6 Qatar AI in Precision Medicine Market Segmentation, By End-User (2020-2032) (USD Billion)
13.5.1.13 Rest Of Middle East
13.5.1.13.1 Rest Of Middle East AI in Precision Medicine Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
13.5.1.13.2 Rest Of Middle East AI in Precision Medicine Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
13.5.1.13.3 Rest Of Middle East AI in Precision Medicine Market Estimates And Forecasts, By Deployment (2020-2032) (USD Billion)
13.5.1.13.4 Rest Of Middle East AI in Precision Medicine Market Estimates And Forecasts, By Therapeutic Area (2020-2032) (USD Billion)
13.5.1.13.5 Rest Of Middle East AI in Precision Medicine Market Estimates And Forecasts, By Application (2020-2032) (USD Billion)
13.5.1.13.6 Rest Of Middle East AI in Precision Medicine Market Segmentation, By End-User (2020-2032) (USD Billion)
13.5.2 Africa
13.5.2.1 Trends Analysis
13.5.2.2 Africa AI in Precision Medicine Market Estimates And Forecasts, By Country (2020-2032) (USD Billion)
13.5.2.3 Africa AI in Precision Medicine Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
13.5.2.4 Africa AI in Precision Medicine Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
13.5.2.5 Africa AI in Precision Medicine Market Estimates And Forecasts, By Deployment (2020-2032) (USD Billion)
13.5.2.6 Africa AI in Precision Medicine Market Estimates And Forecasts, By Therapeutic Area (2020-2032) (USD Billion)
13.5.2.7 Africa AI in Precision Medicine Market Estimates And Forecasts, By Application (2020-2032) (USD Billion)
13.5.2.8 Africa AI in Precision Medicine Market Segmentation, By End-User (2020-2032) (USD Billion)
13.5.2.9 South Africa
13.5.2.9.1 South Africa AI in Precision Medicine Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
13.5.2.9.2 South Africa AI in Precision Medicine Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
13.5.2.9.3 South Africa AI in Precision Medicine Market Estimates And Forecasts, By Deployment (2020-2032) (USD Billion)
13.5.2.9.4 South Africa AI in Precision Medicine Market Estimates And Forecasts, By Therapeutic Area (2020-2032) (USD Billion)
13.5.2.9.5 South Africa AI in Precision Medicine Market Estimates And Forecasts, By Application (2020-2032) (USD Billion)
13.5.2.9.6 South Africa AI in Precision Medicine Market Segmentation, By End-User (2020-2032) (USD Billion)
13.5.2.10 Nigeria
13.5.2.10.1 Nigeria AI in Precision Medicine Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
13.5.2.10.2 Nigeria AI in Precision Medicine Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
13.5.2.10.3 Nigeria AI in Precision Medicine Market Estimates And Forecasts, By Deployment (2020-2032) (USD Billion)
13.5.2.10.4 Nigeria AI in Precision Medicine Market Estimates And Forecasts, By Therapeutic Area (2020-2032) (USD Billion)
13.5.2.10.5 Nigeria AI in Precision Medicine Market Estimates And Forecasts, By Application (2020-2032) (USD Billion)
13.5.2.10.6 Nigeria AI in Precision Medicine Market Segmentation, By End-User (2020-2032) (USD Billion)
13.5.2.11 Rest Of Africa
13.5.2.11.1 Rest Of Africa AI in Precision Medicine Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
13.5.2.11.2 Rest Of Africa AI in Precision Medicine Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
13.5.2.11.3 Rest Of Africa AI in Precision Medicine Market Estimates And Forecasts, By Deployment (2020-2032) (USD Billion)
13.5.2.11.4 Rest Of Africa AI in Precision Medicine Market Estimates And Forecasts, By Therapeutic Area (2020-2032) (USD Billion)
13.5.2.11.5 Rest Of Africa AI in Precision Medicine Market Estimates And Forecasts, By Application (2020-2032) (USD Billion)
13.5.2.11.6 Rest Of Africa AI in Precision Medicine Market Segmentation, By End-User (2020-2032) (USD Billion)
13.6 Latin America
13.6.1 Trends Analysis
13.6.2 Latin America AI in Precision Medicine Market Estimates And Forecasts, By Country (2020-2032) (USD Billion)
13.6.3 Latin America AI in Precision Medicine Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
13.6.4 Latin America AI in Precision Medicine Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
13.6.5 Latin America AI in Precision Medicine Market Estimates And Forecasts, By Deployment (2020-2032) (USD Billion)
13.6.6 Latin America AI in Precision Medicine Market Estimates And Forecasts, By Therapeutic Area (2020-2032) (USD Billion)
13.6.7 Latin America AI in Precision Medicine Market Estimates And Forecasts, By Application (2020-2032) (USD Billion)
13.6.8 Latin America AI in Precision Medicine Market Segmentation, By End-User (2020-2032) (USD Billion)
13.6.9 Brazil
13.6.9.1 Brazil AI in Precision Medicine Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
13.6.9.2 Brazil AI in Precision Medicine Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
13.6.9.3 Brazil AI in Precision Medicine Market Estimates And Forecasts, By Deployment (2020-2032) (USD Billion)
13.6.9.4 Brazil AI in Precision Medicine Market Estimates And Forecasts, By Therapeutic Area (2020-2032) (USD Billion)
13.6.9.5 Brazil AI in Precision Medicine Market Estimates And Forecasts, By Application (2020-2032) (USD Billion)
13.6.9.6 Brazil AI in Precision Medicine Market Segmentation, By End-User (2020-2032) (USD Billion)
13.6.10 Argentina
13.6.10.1 Argentina AI in Precision Medicine Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
13.6.10.2 Argentina AI in Precision Medicine Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
13.6.10.3 Argentina AI in Precision Medicine Market Estimates And Forecasts, By Deployment (2020-2032) (USD Billion)
13.6.10.4 Argentina AI in Precision Medicine Market Estimates And Forecasts, By Therapeutic Area (2020-2032) (USD Billion)
13.6.10.5 Argentina AI in Precision Medicine Market Estimates And Forecasts, By Application (2020-2032) (USD Billion)
13.6.10.6 Argentina AI in Precision Medicine Market Segmentation, By End-User (2020-2032) (USD Billion)
13.6.11 Colombia
13.6.11.1 Colombia AI in Precision Medicine Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
13.6.11.2 Colombia AI in Precision Medicine Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
13.6.11.3 Colombia AI in Precision Medicine Market Estimates And Forecasts, By Deployment (2020-2032) (USD Billion)
13.6.11.4 Colombia AI in Precision Medicine Market Estimates And Forecasts, By Therapeutic Area (2020-2032) (USD Billion)
13.6.11.5 Colombia AI in Precision Medicine Market Estimates And Forecasts, By Application (2020-2032) (USD Billion)
13.6.11.6 Colombia AI in Precision Medicine Market Segmentation, By End-User (2020-2032) (USD Billion)
13.6.12 Rest of Latin America
13.6.12.1 Rest of Latin America AI in Precision Medicine Market Estimates And Forecasts, By Component (2020-2032) (USD Billion)
13.6.12.2 Rest of Latin America AI in Precision Medicine Market Estimates And Forecasts, By Technology (2020-2032) (USD Billion)
13.6.12.3 Rest of Latin America AI in Precision Medicine Market Estimates And Forecasts, By Deployment (2020-2032) (USD Billion)
13.6.12.4 Rest of Latin America AI in Precision Medicine Market Estimates And Forecasts, By Therapeutic Area (2020-2032) (USD Billion)
13.6.12.5 Rest of Latin America AI in Precision Medicine Market Estimates And Forecasts, By Application (2020-2032) (USD Billion)
13.6.12.6 Rest of Latin America AI in Precision Medicine Market Segmentation, By End-User (2020-2032) (USD Billion)
14. Company Profile0s
14.1 Tempus AI, Inc.
14.1.1Company Overview
14.1.2 Financial
14.1.3 Products/ Services Offered
14.1.4 SWOT Analysis
14.2 Exscientia
14.2.1 Company Overview
14.2.2 Financial
14.2.3 Products/ Services Offered
14.2.4 SWOT Analysis
14.3 BenevolentAI
14.3.1 Company Overview
14.3.2 Financial
14.3.3 Products/ Services Offered
14.3.4 SWOT Analysis
14.4 Deep Genomics
14.4.1 Company Overview
14.4.2 Financial
14.4.3 Products/ Services Offered
14.4.4 SWOT Analysis
14.5 Insilico Medicine
14.5.1 Company Overview
14.5.2 Financial
14.5.3 Products/ Services Offered
14.5.4 SWOT Analysis
14.6 PathAI, Inc.
14.6.1 Company Overview
14.6.2 Financial
14.6.3 Products/ Services Offered
14.6.4 SWOT Analysis
14.7 Verge Genomics
14.7.1 Company Overview
14.7.2 Financial
14.7.3 Products/ Services Offered
14.7.4 SWOT Analysis
14.8 Guardant Health, Inc.
14.8.1 Company Overview
14.8.2 Financial
14.8.3 Products/ Services Offered
14.8.4 SWOT Analysis
14.9 Grail, Inc.
14.9.1 Company Overview
14.9.2 Financial
14.9.3 Products/ Services Offered
14.9.4 SWOT Analysis
14.10 Foundation Medicine, Inc.
14.10.1 Company Overview
14.10.2 Financial
14.10.3 Products/ Services Offered
14.10.4 SWOT Analysis
15. Use Cases and Best Practices
16. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Key Segments:
By Component
Software
Hardware
Services
By Technology
Deep Learning
Querying Method
Natural language processing
Context aware processing
Others
By Deployment
Cloud Based
On-Premise
Hybrid
By Therapeutic Area
Oncology
Rare Diseases
Infectious Diseases
Neurology
Cardiology
Hematology
Others
By Application
Drug Discovery & Development
Drug Discovery
Drug Repurposing
De Novo Drug Design
Drug Optimization
Safety & Toxicity
Clinical Development
Diagnostics & Screening
Risk Assessment & Patient Stratification
Disease Screening
Disease Diagnosis
Disease Progression, Staging, And Prognosis
Therapeutics
Therapy Selection & Planning
Therapy Monitoring
Post-Treatment Surveillance & Follow-Up
By End-User
Healthcare Providers
Pharmaceutical & Biotechnology Companies
Medical Device & Equipment Companies
Research Centers, Academic Institutes, And Government Organizations
Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Detailed Volume Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Competitive Product Benchmarking
Geographic Analysis
Additional countries in any of the regions
Customized Data Representation
Detailed analysis and profiling of additional market players
The Antibody Production Market size was estimated at USD 14.33 billion in 2023 and is expected to reach USD 36.49 billion by 2032 at a CAGR of 10.95% during the forecast period of 2024-2032.
Medical Document Management Systems Market was valued at USD 0.63 Bn in 2023 and is expected to reach USD 1.81 Bn by 2032, growing at a CAGR of 12.48%.
The gRNA Market Size was valued at USD 498.30 Million in 2023, and is expected to reach USD 2,303.70 Million by 2032, and grow at a CAGR of 19.61% Over the Forecast Period of 2024-2032.
The Risk-based Monitoring Software Market Size was valued at USD 359.32 Million in 2023, and is expected to reach USD 1004.32 Million by 2031, and grow at a CAGR of 13.71% over the forecast period 2024-2031.
The Medical Marijuana Market Size was valued at USD 16.1 Billion in 2023 and is expected to reach USD 72.1 Billion by 2032, growing at a CAGR of 18.1% over the forecast period 2024-2032
The Antimicrobial Resistance Surveillance Market was valued at USD 5.90 Billion in 2023 and is projected to grow to USD 9.50 billion by 2032 with a CAGR of 5.47% over the forecast period 2024-2032.
Hi! Click one of our member below to chat on Phone
© 2025 All Rights Reserved by SNS Insider Pvt Ltd
